Trident Lifeline share price
BSE: 543616Pharmaceuticals & BiotechnologySmall Cap
Trident Lifeline Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 2022
Last close ₹430.90down ₹3.60 (0.83%)
Share price at the BSE close on 28 Oct 2026. Previous close ₹434.50.
28 Oct: open ₹435.50, high ₹435.50, low ₹420.00
52-week range of traded prices to 28 Oct 2026
₹229.95Low, 24 Mar 2026₹437.90High, 27 Oct 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹516 Cr2,106th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 22.79
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.54
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 24.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.74
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 25,800
Results
Consolidated; ₹ crore.Trident Lifeline quarterly results
Quarter to Sep 2026, against the quarter before
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹47 Crup 39.64%
- Net profitNet profit. The pill is the change in net profit against the quarter before: this period's figure divided by that one's, less one, in per cent. Net profit in the glossary
- ₹6.60 Crup 31.13%
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. Net margin in the glossary
- 14.0%
Revenue by quarter
Peak revenue ₹50 Cr, quarter to Mar 2026; lowest ₹24 Cr, quarter to Jun 2025
Net profit by quarter, a loss in red
| ₹ crore | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|
| Revenue | 23.6 | 29.8 | 25.7 | 50.0 | 33.7 | 47.1 |
| Net profit | 3.1 | 4.9 | 4.3 | 6.7 | 5.0 | 6.6 |
| Net margin | 13.0% | 16.6% | 16.7% | 13.5% | 14.9% | 14.0% |
Consolidated. The last eight quarters. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share. No results on record for the quarters to Dec 2024 and Mar 2025.
Year to Mar 2026, against the year before
- RevenueRevenue. The pill is the change in revenue against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹129 Crup 48.36%
- Net profitNet profit. The pill is the change in net profit against the year before: this period's figure divided by that one's, less one, in per cent.
- ₹19 Crup 62.08%
- Net margin
- 14.8%
Revenue by year
Peak revenue ₹129 Cr, year to Mar 2026; lowest ₹32 Cr, year to Mar 2023
Net profit by year, a loss in red
| ₹ crore | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Revenue | 32 | 45 | 87 | 129 |
| Net profit | 6 | 6 | 12 | 19 |
| Net margin | 19.0% | 14.2% | 13.5% | 14.8% |
Consolidated. Years to March. The latest is shaded. Net profit is the whole group's, the other owners of its subsidiaries included; P/E and ROE use the company's own share.
Business segments
In the year to Mar 2026 the company reports one business segment, PHARMACEUTICAL, which carries all its revenue.
Valuation
Today, against the company's own history. Dividend yield is not shown: no dividend in the years on record.Trident Lifeline PE ratio and valuation
Price to earnings
At or below today's level on 26% of 642 trading days over the last 3 years.
LowestHighest
Its median28.56Industry median28.15
Price to book
At or below today's level on 42% of 642 trading days over the last 3 years.
LowestHighest
Its median4.71Industry median2.94
Where the return came from
Yearly rates to Mar 2026, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | +4.4% | +56.2% | −33.1% | 0.0% |
| 3 years | +19.0% | +45.0% | −17.9% | 0.0% |
Return is price growth plus the average dividend yield. Change in P/E is (1 + price growth) / (1 + earnings growth) - 1, so the parts compound rather than add. Earnings growth over 1 and 3 years is on profit divided by shares in issue at both ends: the earnings per share stated for one end does not match that year's profit and share count.
Promoter and insider buying and selling
Trades made since 29 Oct 2025.Trident Lifeline insider trading
Bought on the marketBought on the market. The value each filer stated for its purchases on the exchange, added up; gifts, transfers and pledges are not counted. A purchase filed with no value is counted under the sum, not in it. Sold on the marketSold on the market. The value each filer stated for its sales on the exchange, added up; gifts, transfers and pledges are not counted. A sale filed with no value is counted under the sum, not in it.
- Promoters and promoter group5 purchases, 7 sales₹0.42 Cr₹5.44 CrNetNet. The value bought on the market less the value sold, over the trades whose filers stated a value.−₹5.02 Cr8 off-market moves
- Others1 purchase, 0 sales₹0.07 CrNo saleNet₹0.07 Cr
Bought and sold count trades on the market only. A pledge is shares given to a lender as security for a loan; a lender invokes it by selling them.
Trident Lifeline competitors and peers
Pharmaceuticals, 215 listed companies, priced on 28 Oct 2026. The table lists the 8 companies closest to Trident Lifeline in market cap.Healthcare companies
Where the company sits among the companies nearest its size
| Company | ||||||||
|---|---|---|---|---|---|---|---|---|
 Valiant LaboratoriesVALIANTLAB | 683 | 42.70 | 2.20 | +89.6% | +12,324.8% | 5.9% | 7.0% | 0.00% |
 Influx HealthtechINFLUX | 625 | 30.41 | 6.20 | – | – | 20.4% | – | 0.00% |
 Amanta HealthcareAMANTA | 623 | 42.42 | 2.83 | – | – | 6.7% | 9.0% | 0.00% |
 WanburyWANBURY | 609 | 10.90 | 4.22 | +3.6% | +30.0% | 54.9% | 23.3% | 0.00% |
 KRM AyurvedaKRMAYURVED | 507 | – | 4.42 | – | – | – | – | 0.00% |
 TranschemTRANSCHEM | 496 | 73.82 | 5.94 | −100.0% | +47.5% | 8.3% | −4.9% | 0.00% |
 Albert DavidALBERTDAVD | 441 | 19.53 | 1.13 | +11.4% | +258.5% | 5.8% | 4.1% | 0.65% |
 Haleos LabsHALEOSLABS | 439 | 27.75 | 2.05 | −3.1% | −8.5% | 7.7% | 7.4% | 0.10% |
Market cap in ₹ crore. Growth is the last twelve months against the twelve before. A figure is left empty where it would rest on a loss or the company has under a year of results on record. ROE is the shareholders' profit over their net worth. ROCE is profit before interest and tax over the whole group's net worth plus borrowings, as in the figures at the top of the page.
Dividends
Per share, by the year it was paid for, and the latest payments.Trident Lifeline dividend history
| Ex-date | Type | Per share |
|---|---|---|
| 30 Oct 2026 | Interim | ₹0.50 |
Latest payments, as declared, by ex-date.
Latest announcements
Routine notices left out.Trident Lifeline announcements
Oct 2026
26 Oct · Dividend
Trident Lifeline share price by year
Each calendar year to 2025.Trident Lifeline share price history
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2025 | 310.70 | +11.0% | 317.70 | 225.00 |
| 2024 | 280.00 | +48.9% | 334.00 | 147.30 |
| 2023 | 188.00 | +51.6% | 227.50 | 117.50 |
| 2022 | 124.00 | – | 158.75 | 108.15 |
₹ per share, adjusted for splits and bonuses since. Change is on the close at the end of the year before. 2022 is from its first session, 10 Oct 2022.
Recent sessions
The 9 trading days to 27 Oct 2026, as traded on BSE; the latest is at the top of the page.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 27 Oct 2026 | 416.95 | 437.90 | 413.00 | 434.50 | 423.11 | 58,200 |
| 26 Oct 2026 | 413.70 | 418.95 | 406.00 | 416.95 | 413.53 | 10,200 |
| 23 Oct 2026 | 381.00 | 410.00 | 381.00 | 407.00 | 398.44 | 10,800 |
| 22 Oct 2026 | 390.00 | 407.95 | 390.00 | 394.25 | 399.14 | 19,800 |
| 21 Oct 2026 | 425.00 | 425.00 | 382.50 | 387.95 | 391.88 | 13,800 |
| 19 Oct 2026 | 410.00 | 412.25 | 401.00 | 402.00 | 408.64 | 34,800 |
| 16 Oct 2026 | 413.75 | 425.00 | 405.00 | 419.90 | 413.96 | 21,600 |
| 15 Oct 2026 | 399.65 | 416.95 | 399.65 | 413.75 | 412.56 | 44,400 |
| 14 Oct 2026 | 384.00 | 419.00 | 384.00 | 402.25 | 406.80 | 80,400 |
Prices in ₹ per share as traded, not adjusted.
Company details
- BSE code
- 543616
- ISIN
- INE0MKA01014
- Industry
- Pharmaceuticals & Biotechnology
- Website
- www.tridentlifeline.com
- CIN
- L51909GJ2014PLC078227
- Corporate identity number, the registrar of companies' code for it
- Incorporated
- 2014
- Registered office
- Shop-2004, 2nd Floor, North Extension, Falsawadi, Begumpura, Nodh-4/1650, Sahara Darwaja, Surat 395003, Gujarat
- Share registrar
- MUFG Intime India Pvt. Ltd
- Keeps the register of shareholders and handles transfers and dividend payments